Unlocking the Potential of PIK3CA: A Key Player in Cancer Therapy The PIK3CA gene, known for encoding the p110α subunit of phosphoinositide 3-kinase (PI3K), stands as one of the most frequently mutated oncogenes across various cancer types. The mutations within PIK3CA are pivotal in driving tumor progression, influencing metabolic pathways, and contributing to treatment resistance. … Read more
Maximizing ADHD Treatment: The Future of Cognitive-Behavioral Therapy Attention-deficit hyperactivity disorder (ADHD) continues to present challenges in everyday life, workplace productivity, and interpersonal relationships. While medication remains a cornerstone for ADHD management, the spotlight on cognitive-behavioral therapy (CBT) components is growing due to their promising non-pharmacological potential. Recent studies have brought an exciting development by … Read more
A Ray of Hope for Children: The Future of Metronomic Chemotherapy in Neuroblastoma Treatment Neuroblastoma, the most common extracranial solid tumor in children, presents a daunting challenge due to its advanced diagnosis in nearly 50% of cases. Despite treatment advancements, survival rates for high-risk and relapsed cases remain disheartening. In resource-limited settings, alternative therapies are … Read more